x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Neurology Today in 5

Neurology Today

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today highlights the most noteworthy and newsworthy neurology stories in the issue.

science & medicine medicine

All Episodes

04:18

Rising incidence of Creutzfeldt-Jakob disease,...

Neurology Today in 5 ·

2024/01/16

Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing the rising incidence of Creutzfeldt-Jakob disease, an effective therapy for prodromal migaine, and neuroinflammation in military personnel exposed to blast injury.

en

04:08

DBS and cognition in severe TBI, in utero exposure to...

Neurology Today in 5 ·

2024/01/02

Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies on the impact of deep brain stimulation on cognition in severe traumatic brain injury and how adaptive functioning is impacted in children exposed to antiseizure drugs in utero, and the editorial board’s picks for the best advances of 2023.

en

04:36

Parkinson’s and suicide risk; biomarkers and...

Neurology Today in 5 ·

2023/12/21

Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing double the suicide risk among Parkinson’s patients; underrepresentation of non-White people in Alzheimer’s trial related to biomarker eligibility; early immune systems changes may play early role in ALS and Parkinson's.

en

04:43

Serotonin and long COVID, Afib detected 3 years after...

Neurology Today in 5 ·

2023/12/07

Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing serotonin depletion associated with long COVID; implantable cardiac monitors detect Afib 3 years post-stroke; and what Medicare’s decision to cover PET amyloid scans means for neurologists.

en

04:49

A promising drug for refractory epilepsy; adverse...

Neurology Today in 5 ·

2023/11/16

Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies on a promising potassium channel opener for refractory epilepsy; the impact of adverse childhood events in headache disorders; and excessive engulfment by microglia/astroctyes in dementia.

en

04:43

Blood transfusions and spontaneous intracerebral...

Neurology Today in 5 ·

2023/11/02

Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new research on the risk of spontaneous intracerebral hemorrhages after blood transfusions; the burden of long distance travel to see neurologists; and two promising biomarkers for early diagnosis of Parkinson’s disease.

en

04:47

Blood pressure and endovascular therapy, cutbacks in...

Neurology Today in 5 ·

2023/10/19

Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new research on blood pressure targets for stroke after endovascular therapy, changing policies on CME, and a direct-to-consumer blood test for Alzheimer’s disease.

en

04:47

Football and Parkinson’s, deep brain stimulation for...

Neurology Today in 5 ·

2023/10/05

Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new research on football and the risk for Parkinson’s disease, the potential of deep brain stimulation for recovery from stroke, and neuroprostheses for patients with anarthria.

en

05:12

Medicare coverage of carotid stenting, disparities in...

Neurology Today in 5 ·

2023/09/21

Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses the Medicare’s proposed coverage of carotid stenting in asymptomatic patients,neuro-oncologists’ perspectives on a federal initiative to target persistent poverty in vulnerable patients, and the technological promise of a new optical EMG for neuromuscular disorders.

en

05:27

Endovascular treatment and intracranial tumors;...

Neurology Today in 5 ·

2023/09/07

Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses research that assesses the safety of endovascular treatment post-stroke for people with intracranial tumors, the AANEM guideline on IVIG use for neuromuscular disorders, and the latest data on donanemab.

en

04:56

Oral health and cognitive decline; managing...

Neurology Today in 5 ·

2023/08/17

Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses studies that associate poor oral health and risk for cognitive decline and how to manage first-ever sleep seizures that recur as well as the growth of concierge neurology.

en

05:43

Gene variants and MS severity, AI and EEG reads,...

Neurology Today in 5 ·

2023/08/03

Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses studies that identify gene variants associated with MS severity/progression, an AI program that read EEGs accurately, and butylphthalide as a promising neuroprotective agent for ischemic stroke.

en

05:12

Antigen tolerance in mouse MS model, epileptiform...

Neurology Today in 5 ·

2023/07/20

Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a novel therapeutic approach that induced antigen tolerance in an MS mouse model, the association between epileptiform activity and ICU outcomes, and an agent, vorasidenib, that slows low-grade gliomas.

en

05:27

Gout and risk of neurodegenereative diseases,...

Neurology Today in 5 ·

2023/07/06

In this week’s podcast, Neurology Today’s editor-in-chief discusses the association between gout and neurodegenerative diseases, tenecrteplase vs.warfarin for acute stroke, expedited cognitive decline after a heart attack.

en

05:29

Antipsychotic for dementia-related agitation,...

Neurology Today in 5 ·

2023/06/15

In this week’s podcast, Neurology Today’s editor-in-chief discusses the FDA approval of an antipsychotic for agitation in dementia, elevated risk for Parkinson’s in Camp Lejeune Marines exposed to contaminated water, a gene variant delays the onset of symptoms in man with autosomal dominant Alzheimer’s. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

en

05:12

OnabotulinumtoxinA for pregnant women with migraine,...

Neurology Today in 5 ·

2023/06/01

In this week’s podcast, Neurology Today’s editor-in-chief discusses a study on the safety of omnabotuliumtoxinA on pregnant women with migraine, the impact of the Adderall shortage on patients with ADHD and narcolepsy, and the state of AI for epilepsy. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

en

05:23

Assay detects Parkinson’s before symptom onset; life...

Neurology Today in 5 ·

2023/05/18

In this week’s podcast, Neurology Today’s editor-in-chief discusses a new study reporting a gene assay detected Parkinson’s before symptoms onset, life stressors greatly impact women with epilepsy during pregnancy; the role of inflammation in new-onset refractory status epilepticus. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

en

05:56

Anticoagulants for patients with dementia and Afib,...

Neurology Today in 5 ·

2023/05/04

In this week’s podcast, Neurology Today’s editor-in-chief discusses a new study finding anticoagulants are safe for patients with atrial fibrillation and dementia, women on hormone replacement therapy had higher tau levels, and neurology residents are participants in humanities programs to foster wellness.

en

05:59

Fertility treatments for women with MS, stroke...

Neurology Today in 5 ·

2023/04/20

In this week’s podcast, Neurology Today’s editor-in-chief discusses a new study finding fertility treatments did not lead to MS relapses for women, a AHA consensus statement that finds stroke systems need improvement, and ravalizumab at less frequent doses was effective for neuromyelitis optica spectrum disorder.

en

06:06

Intranasal CGRP for migraine, ultrasound ablation for...

Neurology Today in 5 ·

2023/04/06

In this week’s podcast, Neurology Today’s editor-in-chief discusses the newly approved zavegepant for migraine, the potential/caveats of ultrasound ablation for Parkinson’s disease, the transational potential of a new therapeutic target for Duchenne muscular atrophy.

en

138 results

Similar Podcasts

Eye On The Sky

Vermont Public

Cienciaes.com

cienciaes.com

This Week in Virology

Vincent Racaniello

Hablando con Científicos - Cienciaes.com

cienciaes.com

The Elective Rotation: A Critical Care Hospital Pharmacy Podcast

Pharmacy Joe